IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

With budgets shrinking healthcare providers are under greater pressure than ever to deliver value, optimizing procedures and providing cost-and time-efficient care. Point-of-care testing can support this—equipping healthcare professionals with the information they need to make smart, on-the-spot medical decisions that improve workflow efficiency and, ultimately, patient outcomes.

As a leader in health technology, our goal at Philips is to revolutionize healthcare management. Where currently diagnostic blood testing is often carried out in a laboratory setting, we’re innovating to move beyond these walls and bring it near the patient—wherever they need it.

In 2016, we took our first step toward achieving this goal, launching the Minicare I-20 handheld system with cardiac troponin-l (cTnI) assay for suspected heart attack, delivering lab comparable results within just 10 minutes.

Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care

Now we have reached another important milestone with the launch of additional next generation Minicare in-vitro diagnostics systems:

• The Minicare C-300*—a clinical chemistry system that enables physicians to bypass the often time-consuming process of sending blood samples to a central or external laboratory for an extensive range of 27 chemistry parameters

• The Minicare H-300*—a hemostasis system that aids in the diagnosis and monitoring of coagulation abnormalities, giving the physicians crucial information in real time in critical care settings such as heavy blood trauma or massive surgery

• Minicare BNP*, an additional cardiac assay for the Minicare I-20, measuring the BNP (Brain Natriuretic Peptide) concentration in blood, to aid in the diagnosis of heart failure providing lab comparable test results within 10 minutes

By providing advanced clinical information through meaningful, cost-efficient and connected solutions, Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care.

With these advanced technologies and easy to use systems, Philips is helping to supply care providers with all the information they need to make decisions in the moments that matter, supporting them to streamline the patient journey and ensure that each individual gets the care they need.

Read Also

Day in the Life of COVID Reporting

Day in the Life of COVID Reporting

Amber Theel, System Director - Patient Safety and Quality, Adventist Health
Healthcare Quality: Who is in charge and why?

Healthcare Quality: Who is in charge and why?

Steve Tierney MD, Sr. Medical Director Quality Improvement, South central Foundation
In the Age of COVID: The Acceleration of Technology

In the Age of COVID: The Acceleration of Technology

Lynn Gibson, VP/Chief Technology Officer, Christus Health
Revamping Workflow in Pharma Industry with Technology

Revamping Workflow in Pharma Industry with Technology

Bozidar Jovicevic, VP, Global Head of Digital Therapeutics, Sanofi [EPA:SAN]
Progressive Innovation Improving Patient Outcomes

Progressive Innovation Improving Patient Outcomes

Emanuele Degortes, Head of Patient, Innovation and Access Policy, Vifor Pharma